Ireland: Biosynth Carbosynth expands IVD offering with acquisition of Aalto Bio Reagents

Urs Spitz (left) – CEO and President, Biosynth Carbosynth and Philip Noone (right) – CEO, Aalto Bio Reagents

KKR-backed Biosynth Carbosynth, a materials supplier to the life science industry, has acquired Ireland-based Aalto Bio Reagents is a global provider of proteins, antigens, HIV antibodies…

You must be a HMI Subscriber to view this content.

Subscribe Now »